The Irresistible Pull of Paramagnetic Beads
June 29, 2023
Share this event
What is SPRI technology, exactly? And what role does it play in genomic reagents? These are both great questions that we hear from time to time from researchers who are trying to find the right chemistries for their lab.
The answer: SPRI technology uses paramagnetic beads to selectively bind nucleic acids by type and size. It enables chemistries to deliver high-performance isolation, purification and cleanup protocols in support of applications such as next-generation sequencing, Sanger sequencing, qPCR, ddPCR and microarrays.
Join us on Thursday, June 29 as Lori Euler—a senior manager of the genomics drug discovery product management team here at Beckman Coulter Life Sciences—takes an in-depth look at the benefits of reagents powered by SPRI technology and offers up insights about:
- The advantages of a bead-based nucleic acid extraction or cleanup
- Which applications are improved with the use of SPRI beads
- How to incorporate SPRI beads into your workflow
Registration is now open—save your seat today.
Get to Know Lori
Lori Euler has over 20 years of experience working in research and development labs in the areas of microbiology and molecular biology.
In 1999, Lori joined DuPont as a staff scientist. Throughout her 16 years with the company, she helped to engineer bacterial strains to produce a variety of compounds as part of their Green Chemistry initiative. She then went on to hold product management roles with Pall Corporation before joining Beckman Coulter Life Sciences in 2022 where she’s a senior manager of the genomics drug discovery product management team.
Lori earned a Bachelor of Science degree in microbiology at Rutgers University and a Master of Science degree in biomedical chemistry at Thomas Jefferson University. She has extensive publications, presentations and patents in her name, detailing her protocol and process development in the areas of metabolic engineering and bacterial strain analysis.